Zhi et al. demonstrated that the protective effect of notoginsenoside R1 on an APP/PS1 double-transgenic mouse model of Alzheimer’s disease was connected with its ability to inhibit Aβ accumulation [249]. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.